Clinically Meaningful Change in Sexual Desire in the Psychosexual Daily Questionnaire in Older Men from the TTrials.


Journal

The journal of sexual medicine
ISSN: 1743-6109
Titre abrégé: J Sex Med
Pays: Netherlands
ID NLM: 101230693

Informations de publication

Date de publication:
07 2019
Historique:
received: 11 02 2019
revised: 29 03 2019
accepted: 03 04 2019
pubmed: 19 5 2019
medline: 24 6 2020
entrez: 19 5 2019
Statut: ppublish

Résumé

A recent study of older men participating in the Testosterone Trials (TTrials) defined a clinically meaningful change in the Psychosexual Daily Questionnaire (PDQ) question 4 in hypogonadal men age ≥65 years. This study defines clinically meaningful change in the same population for sexual desire assessed by PDQ question 1. To determine a clinically meaningful change in the answers to question 1 of the PDQ in hypogonadal older men. Participants in the Sexual Function Trial of the TTrials were randomly divided into a training and test set. Anchor-based methods, including regression analysis, receiver operating characteristic curves, and empirical cumulative distribution functions, were used to determine a clinically meaningful change on question 1 in the training set, and the selected threshold was evaluated in the test set for an effect of testosterone treatment. A clinically meaningful increase in question 1 of the PDQ was determined to be ≥0.7 points. Question 1 of the PDQ can be used to assess sexual desire in response to testosterone treatment. Data were obtained from a single large study of older hypogonadal men. Clinically meaningful improvement of sexual desire is a change of ≥0.7 in the score of question 1 of the PDQ. Stephens-Shields AJ, Wang C, Preston P, et al. Clinically Meaningful Change in Sexual Desire in the Psychosexual Daily Questionnaire in Older Men from the TTrials. J Sex Med 2019;16:951-953.

Sections du résumé

BACKGROUND
A recent study of older men participating in the Testosterone Trials (TTrials) defined a clinically meaningful change in the Psychosexual Daily Questionnaire (PDQ) question 4 in hypogonadal men age ≥65 years. This study defines clinically meaningful change in the same population for sexual desire assessed by PDQ question 1.
AIM
To determine a clinically meaningful change in the answers to question 1 of the PDQ in hypogonadal older men.
METHODS
Participants in the Sexual Function Trial of the TTrials were randomly divided into a training and test set. Anchor-based methods, including regression analysis, receiver operating characteristic curves, and empirical cumulative distribution functions, were used to determine a clinically meaningful change on question 1 in the training set, and the selected threshold was evaluated in the test set for an effect of testosterone treatment.
RESULTS
A clinically meaningful increase in question 1 of the PDQ was determined to be ≥0.7 points.
CLINICAL IMPLICATIONS
Question 1 of the PDQ can be used to assess sexual desire in response to testosterone treatment.
STRENGTHS & LIMITATIONS
Data were obtained from a single large study of older hypogonadal men.
CONCLUSION
Clinically meaningful improvement of sexual desire is a change of ≥0.7 in the score of question 1 of the PDQ. Stephens-Shields AJ, Wang C, Preston P, et al. Clinically Meaningful Change in Sexual Desire in the Psychosexual Daily Questionnaire in Older Men from the TTrials. J Sex Med 2019;16:951-953.

Identifiants

pubmed: 31101538
pii: S1743-6095(19)31110-5
doi: 10.1016/j.jsxm.2019.04.003
pmc: PMC7359814
mid: NIHMS1529739
pii:
doi:

Substances chimiques

Testosterone 3XMK78S47O

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

951-953

Subventions

Organisme : NIA NIH HHS
ID : U01 AG030644
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States

Informations de copyright

Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Références

J Sex Med. 2018 Jul;15(7):997-1009
pubmed: 29960633
J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53
pubmed: 10946892
N Engl J Med. 2016 Feb 18;374(7):611-24
pubmed: 26886521
J Androl. 2003 Sep-Oct;24(5):688-98
pubmed: 12954659
J Clin Endocrinol Metab. 2003 Jun;88(6):2673-81
pubmed: 12788872
Stat Methods Med Res. 2014 Oct;23(5):460-83
pubmed: 23427226
J Urol. 2019 Mar;201(3):587-594
pubmed: 30296416
Clin Endocrinol (Oxf). 2011 Dec;75(6):836-43
pubmed: 21689131

Auteurs

Alisa J Stephens-Shields (AJ)

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: alisaste@pennmedicine.upenn.edu.

Christina Wang (C)

Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, CA, USA.

Peter Preston (P)

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Peter J Snyder (PJ)

Division of Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Ronald S Swerdloff (RS)

Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH